Aryl hydrocarbon receptor nuclear translocator (ARNT) isoforms control lymphoid cancer cell proliferation through differentially regulating tumor suppressor p53 activity

Oncotarget
Kacie A GardellaCasey W Wright

Abstract

The aryl hydrocarbon receptor nuclear translocator (ARNT) is involved in xenobiotic and hypoxic responses, and we previously showed that ARNT also regulates nuclear factor-κB (NF-κB) signaling by altering the DNA binding activity of the RelB subunit. However, our initial study of ARNT-mediated RelB modulation was based on simultaneous suppression of the two ARNT isoforms, isoform 1 and 3, and precluded the examination of their individual functions. We find here that while normal lymphocytes harbor equal levels of isoform 1 and 3, lymphoid malignancies exhibit a shift to higher levels of ARNT isoform 1. These elevated levels of ARNT isoform 1 are critical to the proliferation of these cancerous cells, as suppression of isoform 1 in a human multiple myeloma (MM) cell line, and an anaplastic large cell lymphoma (ALCL) cell line, triggered S-phase cell cycle arrest, spontaneous apoptosis, and sensitized cells to doxorubicin treatment. Furthermore, co-suppression of RelB or p53 with ARNT isoform 1 prevented cell cycle arrest and blocked doxorubicin induced apoptosis. Together our findings reveal that certain blood cancers rely on ARNT isoform 1 to potentiate proliferation by antagonizing RelB and p53-dependent cell cycle arrest and ...Continue Reading

References

Dec 31, 2002·Cancer Genetics and Cytogenetics·Jean GogusevChristian Nezelof
Dec 4, 2003·The International Journal of Biochemistry & Cell Biology·Robyn J KewleyAnne Chapman-Smith
Sep 1, 2005·Biochemical and Biophysical Research Communications·Robyn J Kewley, Murray L Whitelaw
Jun 22, 2006·Trends in Genetics : TIG·Donna G Albertson
Oct 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Andreas C JoergerAlan R Fersht
Jan 31, 2007·The Journal of Biological Chemistry·Casey W WrightColin S Duckett
Mar 30, 2007·Nature·Fumiaki OhtakeShigeaki Kato
May 24, 2007·Blood·Hesham M Amin, Raymond Lai
Aug 19, 2007·Cancer Cell·Jonathan J KeatsP Leif Bergsagel
Feb 13, 2008·Cell·Matthew S Hayden, Sankar Ghosh
Mar 7, 2008·Journal of Cell Science·Margaret J WheelockKeith R Johnson
Mar 18, 2008·Cell Death and Differentiation·N S Chandel, M C Simon
Jan 8, 2010·Blood·Yulia N DemchenkoW Michael Kuehl
Feb 6, 2010·Science·Reini F LucoTom Misteli
Feb 13, 2010·Annual Review of Physiology·Brian E McIntoshChristopher A Bradfield
Feb 19, 2010·Nature·Rameen BeroukhimMatthew Meyerson
Jan 11, 2011·Cell·Reini F LucoTom Misteli
Mar 29, 2011·Nature·Jason ErnstBradley E Bernstein
Oct 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Francesca ZammarchiLuca Cartegni
Jan 20, 2012·Nature Reviews. Cancer·Neil D Perkins
Mar 20, 2012·Cell·Pietro Spitali, Annemieke Aartsma-Rus
Sep 8, 2012·Nature·UNKNOWN ENCODE Project Consortium
Oct 2, 2012·The Journal of Clinical Investigation·W Michael Kuehl, P Leif Bergsagel
Apr 24, 2013·Nature Reviews. Genetics·Rebecca J FaircloughKay E Davies
Nov 20, 2013·Pediatric Blood & Cancer·Hacı Ahmet DemirSerdar Ceylaner
Nov 23, 2013·Nature Reviews. Cancer·David C BerstenMurray L Whitelaw
Mar 25, 2014·Annual Review of Immunology·Brigitta StockingerJoão H Duarte
Jun 6, 2014·PLoS Computational Biology·Ondrej PodlahaFranziska Michor

❮ Previous
Next ❯

Citations

Nov 22, 2017·Scientific Reports·Tânia R MielckeMaria M Campos
Mar 31, 2019·Molecular Cancer·Nancy T CheeShaun P Brothers
Nov 20, 2018·EFSA Journal·UNKNOWN EFSA Panel on Contaminants in the Food Chain (CONTAM)Laurentius Ron Hoogenboom
Jul 29, 2016·Aging·Kacie A GardellaCasey W Wright
Dec 13, 2017·Scientific Reports·Jin-Yong LeeMasahiko Satoh
May 1, 2021·Biomolecules·Concetta PanebiancoValerio Pazienza

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
transfection
PCR
antisense oligonucleotide

Software Mentioned

Sim
FlowJo
Epigenome Roadmap
ARNT
siControl
Per

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.